The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
about
Dyslipidemia in Dermatological DisordersA model for lupus brain diseaseMetabolic abnormalities and cardiovascular risk factors in children with myositisInflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.Is atherosclerosis an autoimmune disease?IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS andEffect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritisAbundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms.Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative GroupsAdipokines, diabetes and atherosclerosis: an inflammatory association.Role of resistin as a marker of inflammation in systemic lupus erythematosus.Predictors of Atherosclerosis in Ankylosing Spondylitis.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisPsoriatic arthritis and diabetes: a population-based cross-sectional studyInflammation and oxidative stress in obstructive sleep apnea syndrome.The consequences of apoptosis in autoimmunity.Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO SyndromeCommon inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients.Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.Inflammation and atherosclerosis: direct versus indirect mechanismsFocus on the potential effects of treatments for spondylarthritides on cardiovascular risk.Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.Atherosclerotic vascular disease in the autoimmune rheumatologic patient.Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus?Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver.Clinical analysis of leg ulcers and gangrene in rheumatoid arthritis.
P2860
Q26771723-BD2F549A-E77D-4D77-9F3D-220F76F35D3FQ26824461-84F1832F-4CF4-404A-B0C2-6BC0FC94B686Q33602858-FEA3D7A0-BCC7-455A-AFF6-694ACE37586CQ33891946-2B376B7A-8459-49D4-B37A-DEC717C717C9Q34104339-949E40AE-30CC-4E38-AACF-E1C390A80A84Q34119124-1A200EC3-CEB7-4A3B-B768-8F907AE673B8Q35123740-B5339DAF-33D5-43AB-85A3-5489C0B2D87CQ35162593-C36DEEC6-4B9F-4EF2-8278-0DA2DBE07727Q35185494-6E08849C-F3C7-42A6-A78E-8FDBC8B5826DQ35581715-02243344-9716-42BF-B2ED-CE9890E29C52Q35597343-D7C2A56A-AF7E-4917-A02A-C3F11DD293E8Q35673987-F848944D-847B-41E2-811D-9517F9F4DCB4Q35924733-4B09877A-EDD4-4281-8EC0-1580EFEEE510Q36241112-F3F0BF1A-D7A3-40FB-8E97-49177C70DC7DQ36641497-8C2A4D54-B4CE-4233-931B-BA87F57B0A77Q36943007-687B1BD3-1503-420F-9BBA-967BB74A6B81Q36955395-AE453007-55D0-4291-B11C-C9EFCFFEDC2EQ36988417-58B73C16-3CAE-4AA6-8AD3-AB45A1497065Q37015165-797C3A58-C5FB-47DC-8613-039F8BA0D160Q37177836-7C439668-A78D-457B-B9E1-05F0815F8E8CQ37209974-0E5F2522-7325-4D8F-B094-5E53AAD56B92Q37300823-F228A8B4-3CD4-4F0E-B5D7-7E1A23EE6708Q37336947-019B0228-E767-4284-9287-E5A46792F0DBQ37478992-2B39E1F5-8F80-4C1F-B0EC-BF1F9F0769B9Q37690591-25F45A56-34BF-476A-91A2-466536142B36Q37723293-7B9807BB-E3F7-45A7-B08F-B52AC854B6ABQ37883018-CFD88695-0287-495C-A4A1-DBE7CC582F31Q38025994-652D572C-4B50-4DAA-A37B-5612CDC83043Q38026796-60A8A1C9-68D5-4598-B500-144ED5E3B963Q38077322-467B6169-78C0-4CA6-9B78-EEF991CFB105Q38177340-0DD32442-F3DE-49BB-90F5-E5807986837FQ38181566-ADD80F20-D49B-4F4F-B3C0-67EF6D5FB656Q38365624-642388FC-2E3F-4C4B-8AEB-1AC3FCB7EBEAQ38654271-B15078ED-313A-4CA5-B620-169CCB3D28C9Q38663003-B4768175-BBB3-4661-A4C0-2851FD0BC054Q38711954-8310BA73-C8D3-4FF5-92AA-97674C929A48Q39078542-EF934053-C1E7-4777-B832-F8E2FED85B41Q39600465-C6D32554-71E5-4E3F-A5F6-EDC880838784Q40120793-79D4F81D-618C-432E-B17B-28687AB1AAD4Q40155381-2EF06348-8041-4A3C-BDC4-C2795A27C1E2
P2860
The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@ast
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@en
type
label
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@ast
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@en
prefLabel
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@ast
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@en
P2093
P1476
The pathogenesis of atheroscle ...... inflammation and dyslipidemia.
@en
P2093
Bevra H Hahn
Jennifer Grossman
Maureen McMahon
Weiling Chen
P356
10.1016/J.JAUT.2007.02.004
P577
2007-03-01T00:00:00Z